榜单:2017年中国医药工业更具成长力企业10强!

2017-09-02 医药地理 医药地理

9月2日,“2017年中国医药工业最具成长力企业”榜单在2017年(第34届)全国医药工业信息年会上隆重揭晓。江西济民可信集团有限公司、人福医药集团股份公司、山西振东健康产业集团有限公司等知名企业上榜。为深入研究行业发展状况、挖掘行业成长潜力最为卓越的企业、树立成长性企业标杆,从2015年开始,全国医药工业信息年会主办方中国医药工业信息中心联合中国医药工业研究总院、上海医药工业研究院组成专家评选小

9月2日,“2017年中国医药工业最具成长力企业”榜单在2017年(第34届)全国医药工业信息年会上隆重揭晓。江西济民可信集团有限公司、人福医药集团股份公司、山西振东健康产业集团有限公司等知名企业上榜。

为深入研究行业发展状况、挖掘行业成长潜力最为卓越的企业、树立成长性企业标杆,从2015年开始,全国医药工业信息年会主办方中国医药工业信息中心联合中国医药工业研究总院、上海医药工业研究院组成专家评选小组,对医药工业领域企业进行基于客观数据的研究与分析,首次推出了2015年中国医药工业最具成长力企业榜单。2017年,新一届中国医药工业最具成长力企业榜单将继续挖掘医药行业内最具成长潜力的企业。 



榜单评选依据
数据来源:《中国医药统计年报》、中国新药研发监测数据库、药物综合数据库、行业专家访谈及其他公开渠道信息。

评价依据:分为产品和企业两个层面,在产品层面考察创新维度、布局维度、地位维度、潜力维度和竞争维度;在企业层面考察引领维度、规模维度、稳定维度、成长维度和战略维度,评审小组针对各维度对各企业进行评分。

产品评选组和企业评选组两个独立的专家团队,分别对产品和企业的几个维度值设立打分标准;接着由综合评判组专家对各维度在综合评判中所占的比重给予系数调整权重,并与标准分值相乘;加权计算后获得企业的综合得分。企业的最终排名由综合得分决定。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2079757, encodeId=77ff20e9757da, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Fri Dec 22 11:41:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705003, encodeId=ae0d1e05003c1, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Oct 30 21:41:00 CST 2017, time=2017-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409040, encodeId=22f91409040c0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456117, encodeId=c3e5145611ea2, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239796, encodeId=341f239e96dc, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Sep 02 19:38:04 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2079757, encodeId=77ff20e9757da, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Fri Dec 22 11:41:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705003, encodeId=ae0d1e05003c1, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Oct 30 21:41:00 CST 2017, time=2017-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409040, encodeId=22f91409040c0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456117, encodeId=c3e5145611ea2, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239796, encodeId=341f239e96dc, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Sep 02 19:38:04 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-10-30 gwc393
  3. [GetPortalCommentsPageByObjectIdResponse(id=2079757, encodeId=77ff20e9757da, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Fri Dec 22 11:41:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705003, encodeId=ae0d1e05003c1, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Oct 30 21:41:00 CST 2017, time=2017-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409040, encodeId=22f91409040c0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456117, encodeId=c3e5145611ea2, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239796, encodeId=341f239e96dc, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Sep 02 19:38:04 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-04 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=2079757, encodeId=77ff20e9757da, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Fri Dec 22 11:41:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705003, encodeId=ae0d1e05003c1, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Oct 30 21:41:00 CST 2017, time=2017-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409040, encodeId=22f91409040c0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456117, encodeId=c3e5145611ea2, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239796, encodeId=341f239e96dc, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Sep 02 19:38:04 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-04 hyf030
  5. [GetPortalCommentsPageByObjectIdResponse(id=2079757, encodeId=77ff20e9757da, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Fri Dec 22 11:41:00 CST 2017, time=2017-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705003, encodeId=ae0d1e05003c1, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Oct 30 21:41:00 CST 2017, time=2017-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409040, encodeId=22f91409040c0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456117, encodeId=c3e5145611ea2, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Sep 04 05:41:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239796, encodeId=341f239e96dc, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Sep 02 19:38:04 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-02 131****1460

    学习了受益匪浅.

    0

相关资讯

2015年药企百强排行榜,很低门槛21亿

7月12日,由中国医药工业信息中心主办并承办的第32届全国医药工业信息年会在成都隆重召开。大会由工业和信息化部消费品工业司副司长吴海东发表开幕致辞。四川省人民政府副省长陈文华,成都市市委常委、高新区管委会党工委书记吴凯代表当地政府出席会议并致辞。会议期间,中国工程院院士桑国卫、工业和信息化部总工程师朱宏任分别做了精彩的主题报告。国家药典委员会秘书长张伟、国家卫生和计划生育委员会药政司副巡视员朱洪彪

榜单:2017年中国医药研发产品线更佳工业企业20强!

9月2日,“2017年中国医药研发产品线最佳工业企业”榜单在2017年(第34届)全国医药工业信息年会上隆重揭晓。正大天晴药业集团股份有限公司、江苏豪森药业集团有限公司、山东罗欣药业集团股份有限公司、江苏恒瑞医药股份有限公司、上海医药集团股份有限公司等知名药企均在榜单上。为了实时追踪国内外研发动态、挖掘出国内医药研发领域的最强音,从2010年开始,全国医药工业信息年会主办方中国医药工业信息中心联合

工信部2016年度医药工业百强榜!

9月2日,由中国医药工业信息中心主办的2017年(第34届)全国医药工业信息年会在成都盛大开幕,大会隆重发布了备受行业关注的工信部2016年度中国医药工业百强企业榜单。扬子江药业集团有限公司、广州医药集团有限公司、修正药业集团股份有限公司位列前三甲。根据中国医药工业信息中心的统计和分析,2016年度百强企业的整体规模延续了一贯的迅猛增长势头。按可比标准计算,本届百强企业累计实现医药工业主营业务收入

解读:2016年度中国医药工业百强榜单评析

2016年是“十三五”规划实施的元年,国家经济结构日益优化,整体经济形势呈现“缓中趋稳、稳中向好”的态势。一年间,20多份落实“三去一降一补”的细则文件密集出台,供给侧改革完成了从概念到落地的过程,成效初现。在此背景下,中国医药产业继续保持着稳中有进的态势,各项改革工作全面铺开,医药企业积极配合,共同实现了“十三五”良好开局。从2016年医药工业主要经济指标来看,主营业务收入和利润总额增速较2

2014中国名医百强榜单完整版

中国名医百强榜是指一位从医十几年的外科医生带领他的团队,历时五年,跨越了全国20个省市自治区,调研200家医院,查询了3000名医生的专长、手术量、科研成果。将临床最常见的14个科室细分为81个专业,再从每个专业中筛选出顶尖高手,最后评选出一百位中国名医,所形成的榜单。2014年度的中国名医百强榜收录了600名一线临床外科专家。上榜专家均来自一线临床,他们有的是国际上该专业的创建者,有的是在国内率

重磅!2016中国大医院门诊量百强榜出炉

中国大医院门诊量百强究竟是哪些医院?哪些医院门急诊量在过去一年里大幅增长?继去年推出2015年中国大医院门诊量排行榜后,2017年3月,《看医界》再次重磅推出“2016年中国大医院门诊量百强榜”。